CN103041301A - Traditional Chinese medicine composition for treating icterohepatitis - Google Patents
Traditional Chinese medicine composition for treating icterohepatitis Download PDFInfo
- Publication number
- CN103041301A CN103041301A CN2012105605232A CN201210560523A CN103041301A CN 103041301 A CN103041301 A CN 103041301A CN 2012105605232 A CN2012105605232 A CN 2012105605232A CN 201210560523 A CN201210560523 A CN 201210560523A CN 103041301 A CN103041301 A CN 103041301A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- radix
- medicine composition
- icterohepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 47
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 3
- 210000000582 semen Anatomy 0.000 claims description 20
- 239000002994 raw material Substances 0.000 claims description 11
- 210000003038 endothelium Anatomy 0.000 claims description 10
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 8
- 235000014375 Curcuma Nutrition 0.000 claims description 2
- 244000164439 Curcuma angustifolia Species 0.000 claims description 2
- 241001529553 Scoparia <angiosperm> Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 21
- 239000008280 blood Substances 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 10
- 210000000952 spleen Anatomy 0.000 abstract description 10
- 206010023126 Jaundice Diseases 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 210000002784 stomach Anatomy 0.000 abstract description 5
- 238000010792 warming Methods 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 244000170916 Paeonia officinalis Species 0.000 abstract 2
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 2
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 239000001215 curcuma longa l. root Substances 0.000 abstract 1
- 210000004317 gizzard Anatomy 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 208000004880 Polyuria Diseases 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 210000003786 sclera Anatomy 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 238000007449 liver function test Methods 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 241001662043 Icterus Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- BPYKTIZUTYGOLE-UHFFFAOYSA-N billirubin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(C=C3C(=C(C=C)C(=O)N3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000009527 percussion Methods 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating the icterohepatitis. The traditional Chinese medicine composition is composed of raw traditional Chinese medicine materials in parts by weight as follows: 10-30 parts of virgate wormwood herbs, 5-15 parts of gardenia, 5-15 parts of rhubarb, 5-25 parts of polygonum cuspidatum, 5-15 parts of radix bupleuri, 10-30 parts of red paeony roots, 15-25 parts of white paeony roots, 10-20 parts of turmeric root tubers, 5-25 parts of gizzard membranes, 5-15 parts of liquorice, 10-20 parts of fructus amomi, 5-25 parts of plantain seeds and 20-40 parts of coix seeds. The traditional Chinese medicine composition has the functions of warming the spleen and the stomach for dispelling cold, invigorating the spleen to remove dampness, removing heat to cool the blood, detoxifying and resuscitating, promoting dieresis and removing jaundice; has a remarkable effect in treating the icterohepatitis, and is reliable in functions; and is wide in component sources, easy to prepare, mild in medicine property, and free of toxic and side effects.
Description
Technical field
The present invention relates to a kind of pharmaceutical product of not determining structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of icterohepatitis.
Background technology
Icterohepatitis is a kind of acute infectious disease of the digestive tract that is caused by hepatitis virus.Be that hepatocyte is destroyed because hepatitis virus makes, hepatic tissue destroys reconstruct, biliary ductuli blocks, cause that conjugated bilirubin and unconjugated bilirubin all increase the symptom that caused skin, mucosa and eyeball sclera etc. partly turn to be yellow in the blood.Clinical manifestation is that onset is anxious, loss of appetite, detest oil, weak, epigastric discomfort, dull pain in liver, feel sick, vomiting, the heating of part patient's fear of cold is then urinated color and is deepened, jaundice appears in sclera, skin etc.Although western medical treatment takes effect obviously at present, also can only solve temporary transient problem.And there is certain side effect in western medicine.
The traditional Chinese medical science thinks that jaundice is to be obstructed by the liver and gall mechanism of qi, and catharsis is not normal.Its cause of disease has the seasonal pathogen of impression epidemic disease poison, or is injury due to diet, or is weakness of the spleen and stomach, and it is suffered from inside and outside often occuring mutually each other.Control suitable warming spleen and stomach for dispelling cold, invigorating the spleen to clear away damp pathogen, heat-clearing and toxic substances removing, removing heat from blood jaundice eliminating.
According to theory of Chinese medical science, for the pathogeny of icterohepatitis, carry out dialectical composition of prescription, to reach the purpose for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
Cure the symptoms, not the disease and deficiency that side effect is large in order to overcome in the prior art to exist, the invention provides a kind of prepare easy, cost is low, the Chinese medicine composition of evident in efficacy, the treatment icterohepatitis that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of icterohepatitis is characterized in that: its raw material of Chinese medicine by following weight portion forms: Herba Artemisiae Scopariae 10-30 part, Fructus Gardeniae 5-15 part, Radix Et Rhizoma Rhei 5-15 part, Rhizoma Polygoni Cuspidati 5-25 part, Radix Bupleuri 5-15 part, Radix Paeoniae Rubra 10-30 part, Radix Paeoniae Alba 15-25 part, Radix Curcumae 10-20 part, Endothelium corneum 5-25 part, Radix Glycyrrhizae 5-15 part, Fructus Amomi 10-20 part, Semen Plantaginis 5-25 part, SEMEN COICIS 20-40 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of icterohepatitis is characterized in that: its raw material of Chinese medicine by following weight portion forms: 20 parts of Herba Artemisiae Scopariaes, 10 parts of Fructus Gardeniaes, 10 parts of Radix Et Rhizoma Rhei, 15 parts of Rhizoma Polygoni Cuspidati, 10 parts of Radix Bupleuri, 20 parts of Radix Paeoniae Rubra, 20 parts of the Radix Paeoniae Albas, 15 parts of Radix Curcumaes, 15 parts of Endothelium corneum, 10 parts in Radix Glycyrrhizae, 15 parts of Fructus Amomis, 15 parts of Semen Plantaginiss, 30 parts of SEMEN COICIS.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In the Chinese medicine composition of the present invention: Herba Artemisiae Scopariae has the effect of clearing away heat-damp and promoting diuresis, hepatic cholagogic; Fructus Gardeniae has the effect of pathogenic fire purging relieving restlessness, clearing away heat-damp and promoting diuresis, removing pathogenic heat from blood and toxic substance from the body; Radix Et Rhizoma Rhei has the effect of pathogenic fire purging removing food stagnancy, heat-clearing and toxic substances removing, cooling blood for hemostasis, blood stasis dispelling cough-relieving; Rhizoma Polygoni Cuspidati has the effect of promoting blood circulation to remove blood stasis, dispelling wind and removing obstruction in the collateral, clearing away heat-damp and promoting diuresis, detoxifcation, relieving cough and resolving phlegm; Radix Bupleuri have evacuate bring down a fever, the effect of yang invigorating soothing liver-QI; Radix Paeoniae Rubra has the effect of clearing away heat and cooling blood, eliminating stasis to stop pain; The Radix Paeoniae Alba has the effect of nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing receipts antiperspirant; Radix Curcumae has the effect of regulating qi to disperse stagnation, heart fire-clearing upset-relieving; Endothelium corneum has controls all a fishbone or other bone caught in the throat, the effect of dysphagic regurgitation of food from the stomach; Radix Glycyrrhizae has the effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription; Fructus Amomi has removing dampness appetizing, warming spleen and stopping diarrha, the antiabortive effect of regulating the flow of vital energy; Semen Plantaginis has the effect of relieving stranguria by diuresis, eliminating dampness by diuresis antidiarrheal, liver heat removing and eyesight improving, removing heat-phlegm; SEMEN COICIS has that inducing diuresis to remove edema, spleen invigorating dry, the effect of arthralgia relieving by relaxing muscles and tendons, clearing away heat and discharging pus.The selected medicament composing prescription of the present invention, its drug component is through dialectical compatibility, complements each other using, and has synergism, play altogether that warming spleen and stomach for dispelling cold, invigorating the spleen to clear away damp pathogen, clearing away heat and cooling blood, detoxifcation are had one's ideas straightened out, the effect of dampness removing jaundice eliminating, the treatment of icterohepatitis is reached treating both the principal and secondary aspects of a disease.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, the medicine source is wide, cost is low.The present invention follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopt the usefulness that is decocted in water for oral dose.Through the clinical practice checking, it is evident in efficacy reliable, and the property of medicine is gentle, toxic and side effects do not occur, and effective percentage reaches 90%, cure rate 70%.
The specific embodiment
The invention will be further described below in conjunction with embodiment.
Embodiment 1
A kind of Chinese medicine composition for the treatment of icterohepatitis, its raw material of Chinese medicine by following weight proportion forms: Herba Artemisiae Scopariae 20g, Fructus Gardeniae 10g, Radix Et Rhizoma Rhei 10g, Rhizoma Polygoni Cuspidati 15g, Radix Bupleuri 10g, Radix Paeoniae Rubra 20g, Radix Paeoniae Alba 20g, Radix Curcumae 15g, Endothelium corneum 15g, Radix Glycyrrhizae 10g, Fructus Amomi 15g, Semen Plantaginis 15g, SEMEN COICIS 30g.
Embodiment 2
A kind of Chinese medicine composition for the treatment of icterohepatitis, its raw material of Chinese medicine by following weight proportion forms: Herba Artemisiae Scopariae 10g, Fructus Gardeniae 15g, Radix Et Rhizoma Rhei 8g, Rhizoma Polygoni Cuspidati 20g, Radix Bupleuri 15g, Radix Paeoniae Rubra 10g, Radix Paeoniae Alba 25g, Radix Curcumae 10g, Endothelium corneum 12g, Radix Glycyrrhizae 5g, Fructus Amomi 12g, Semen Plantaginis 20g, SEMEN COICIS 20g.
Embodiment 3
A kind of Chinese medicine composition for the treatment of icterohepatitis, its raw material of Chinese medicine by following weight proportion forms: Herba Artemisiae Scopariae 30g, Fructus Gardeniae 12g, Radix Et Rhizoma Rhei 5g, Rhizoma Polygoni Cuspidati 10g, Radix Bupleuri 12g, Radix Paeoniae Rubra 30g, Radix Paeoniae Alba 15g, Radix Curcumae 12g, Endothelium corneum 10g, Radix Glycyrrhizae 8g, Fructus Amomi 20g, Semen Plantaginis 25g, SEMEN COICIS 25g.
Embodiment 4
A kind of Chinese medicine composition for the treatment of icterohepatitis, its raw material of Chinese medicine by following weight proportion forms: Herba Artemisiae Scopariae 15g, Fructus Gardeniae 5g, Radix Et Rhizoma Rhei 15g, Rhizoma Polygoni Cuspidati 5g, Radix Bupleuri 8g, Radix Paeoniae Rubra 25g, Radix Paeoniae Alba 20g, Radix Curcumae 15g, Endothelium corneum 25g, Radix Glycyrrhizae 12g, Fructus Amomi 10g, Semen Plantaginis 5g, SEMEN COICIS 40g.
Embodiment 5
A kind of Chinese medicine composition for the treatment of icterohepatitis, its raw material of Chinese medicine by following weight proportion forms: Herba Artemisiae Scopariae 25g, Fructus Gardeniae 8g, Radix Et Rhizoma Rhei 10g, Rhizoma Polygoni Cuspidati 25g, Radix Bupleuri 5g, Radix Paeoniae Rubra 15g, Radix Paeoniae Alba 18g, Radix Curcumae 20g, Endothelium corneum 5g, Radix Glycyrrhizae 15g, Fructus Amomi 15g, Semen Plantaginis 15g, SEMEN COICIS 35g.
Chinese medicine composition in embodiment of the invention decocting method is routinely produced medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, add cold water and cover powder, soaked 15～20 minutes, add water again and do not have about 6 centimetres of powder, decoct.Adopt intense fire to decoct at a simmer, it is rear with slow fire boiling 20～30 minutes to boil; Second decocts, and adds water and does not have about 5 centimetres of powder, the water rear decoction 15～20 minutes of boiling.Decoct extracting juice twice, merge.
A kind of Chinese medicine composition for the treatment of icterohepatitis, clinical efficacy is summed up:
One, general data: this Chinese medicine composition is applied to clinical observation case 50 examples, 20～45 years old age.
Two, usage and dosage: during clinical practice, the amounts of components in the compositions is taken the circumstances into consideration increase and decrease according to patient's body weight and age.One day potion, the about 300ml of twice extracting juice of decocting divides early, takes for late twice.Five days is a course for the treatment of.
Three, criterion of therapeutical effect:
(1) recovery from illness: transference cure, jaundice disappears, and liver function test is normal;
(2) effective: transference cure, jaundice disappears, the liver function test mile abnormality;
(3) invalid: symptom is without obvious improvement.
Four, therapeutic effect: in this clinical observation case, take medicine 1-10 the course for the treatment of, 35 examples of fully recovering are followed up a case by regular visits to and are had no recurrence; Effective 10 examples, invalid 5 examples.Toxic and side effects does not occur during the treatment.
Five, model case:
Case 1:
Grandson, man, 29 years old.Jaundice appears in performance pre-icterus stage of heating, general malaise, weak, loss of appetite, nausea and vomiting, upper right abdomen discomfort etc. after 1 week, and have a medical check-up and find skin, yellow sclera, hepatosplenomegaly, there are tenderness and percussion pain in the hepatic region.Examine and be icterohepatitis.Take 3 courses for the treatment of of medicament of Chinese medicine composition preparation of the present invention, transference cure.
Case 2:
Lin, woman, 38 years old.Examine and see: body, order, urine are all yellow, and heating, the nausea of feeling sick, abdominal distension and anorexia, body are tired weak, red tongue, yellow and greasy fur, wiry and frequent pulse.Examine and be icterohepatitis.Take 3 courses for the treatment of of medicament of Chinese medicine composition preparation of the present invention, symptom disappears substantially, continues to take 2 courses for the treatment of, the symptom complete obiteration.Follow up a case by regular visits to so far without recurrence.
Claims (2)
1. Chinese medicine composition for the treatment of icterohepatitis, it is characterized in that: its raw material of Chinese medicine by following weight portion forms: Herba Artemisiae Scopariae 10-30 part, Fructus Gardeniae 5-15 part, Radix Et Rhizoma Rhei 5-15 part, Rhizoma Polygoni Cuspidati 5-25 part, Radix Bupleuri 5-15 part, Radix Paeoniae Rubra 10-30 part, Radix Paeoniae Alba 15-25 part, Radix Curcumae 10-20 part, Endothelium corneum 5-25 part, Radix Glycyrrhizae 5-15 part, Fructus Amomi 10-20 part, Semen Plantaginis 5-25 part, SEMEN COICIS 20-40 part.
2. a kind of Chinese medicine composition for the treatment of icterohepatitis according to claim 1, it is characterized in that: its raw material of Chinese medicine by following weight portion forms: 20 parts of Herba Artemisiae Scopariaes, 10 parts of Fructus Gardeniaes, 10 parts of Radix Et Rhizoma Rhei, 15 parts of Rhizoma Polygoni Cuspidati, 10 parts of Radix Bupleuri, 20 parts of Radix Paeoniae Rubra, 20 parts of the Radix Paeoniae Albas, 15 parts of Radix Curcumaes, 15 parts of Endothelium corneum, 10 parts in Radix Glycyrrhizae, 15 parts of Fructus Amomis, 15 parts of Semen Plantaginiss, 30 parts of SEMEN COICIS.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210560523.2A CN103041301B (en) | 2012-12-21 | 2012-12-21 | Traditional Chinese medicine composition for treating icterohepatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210560523.2A CN103041301B (en) | 2012-12-21 | 2012-12-21 | Traditional Chinese medicine composition for treating icterohepatitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103041301A true CN103041301A (en) | 2013-04-17 |
| CN103041301B CN103041301B (en) | 2014-07-23 |
Family
ID=48054312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210560523.2A Expired - Fee Related CN103041301B (en) | 2012-12-21 | 2012-12-21 | Traditional Chinese medicine composition for treating icterohepatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103041301B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103721108A (en) * | 2014-01-21 | 2014-04-16 | 唐秀慧 | Medicament for treating acute icteric hepatitis |
| CN104208598A (en) * | 2014-09-26 | 2014-12-17 | 禤燕华 | Chinese medicinal composition for treating chronic jaundice |
| CN105168974A (en) * | 2015-09-18 | 2015-12-23 | 马鞍山德宏堂生物科技有限公司 | Traditional Chinese medicine composition for treating jaundice hepatitis |
-
2012
- 2012-12-21 CN CN201210560523.2A patent/CN103041301B/en not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| 常志南 等: "15例小儿急性黄疸型肝炎的辨证施治", 《黑龙江中医药》 * |
| 楚更五: "病毒性肝炎的中医治疗", 《中国乡村医药杂志》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103721108A (en) * | 2014-01-21 | 2014-04-16 | 唐秀慧 | Medicament for treating acute icteric hepatitis |
| CN103721108B (en) * | 2014-01-21 | 2015-09-23 | 唐秀慧 | A kind of medicament for the treatment of acute icterohepatitis |
| CN104208598A (en) * | 2014-09-26 | 2014-12-17 | 禤燕华 | Chinese medicinal composition for treating chronic jaundice |
| CN105168974A (en) * | 2015-09-18 | 2015-12-23 | 马鞍山德宏堂生物科技有限公司 | Traditional Chinese medicine composition for treating jaundice hepatitis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103041301B (en) | 2014-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103007191B (en) | Chinese medicinal composition for treating jaundice | |
| CN102512630B (en) | Traditional Chinese medicine composition for treating gallbladder calculus | |
| CN103041336B (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN104043022A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN103041301B (en) | Traditional Chinese medicine composition for treating icterohepatitis | |
| CN103041200B (en) | Traditional Chinese medicine composition for treating cerebral hemorrhage | |
| CN102872226B (en) | Traditional Chinese medicine composition for treating arthralgia | |
| CN104173856A (en) | Traditional Chinese medicine composition for treating morbid leukorrhea | |
| CN103721082B (en) | A kind of Chinese medicine composition of cure scapulohumeral periarthritis | |
| CN102357227A (en) | Chinese medicinal composition for treating qi stagnation and blood stasis amenorrhea | |
| CN102512560B (en) | Traditional Chinese medicinal composition for treating arthromyodynia | |
| CN104758720A (en) | Traditional Chinese medicine composition for treating impotence | |
| CN102949659A (en) | Traditional Chinese medicine composition for treating hepatitis B | |
| CN103007213A (en) | Chinese medicinal composition for treating arthralgia | |
| CN102784212B (en) | Chinese medicine composition for treating arthralgia-synadrome | |
| CN102512543B (en) | Chinese medicinal composition for treating rheumatoid arthritis | |
| CN105749167A (en) | Traditional Chinese medicine composition for treating amenorrhea | |
| CN104013765A (en) | Traditional Chinese medicine composition for treating deficiency of liver-yin and kidney-yin | |
| CN103816493B (en) | A kind of Chinese medicine composition treating instability of kidney QI | |
| CN103330814A (en) | Traditional Chinese medicine composition for treating deficiency of kidney yang | |
| CN103550690A (en) | Traditional Chinese medicine composition for treating superficial gastritis | |
| CN103356951B (en) | A kind of Chinese medicine composition for the treatment of cardiac blood supply deficiency | |
| CN102784256B (en) | Chinese medicine composition for treating arthralgia-synadrome | |
| CN105833152A (en) | Traditional Chinese medicine composition for treating endocrine dyscrasia | |
| CN105770374A (en) | Traditional Chinese medicine composition for treating uterine fibroid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140723 Termination date: 20141221 |
|
| EXPY | Termination of patent right or utility model |